相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Targeting transforming growth factor-β signaling in liver metastasis of colon cancer
Bixiang Zhang et al.
CANCER LETTERS (2009)
The Role of Tumor Cell-Derived Connective Tissue Growth Factor (CTGF/CCN2) in Pancreatic Tumor Growth
Kevin L. Bennewith et al.
CANCER RESEARCH (2009)
Targeting Transforming Growth Factor (TGF)-βRI Inhibits Activation of β1 Integrin and Blocks Vascular Invasion in Hepatocellular Carcinoma
Emilia Fransvea et al.
HEPATOLOGY (2009)
Inhibition of Transforming Growth Factor β Receptor I Kinase Blocks Hepatocellular Carcinoma Growth Through Neo-angiogenesis Regulation
Antonio Mazzocca et al.
HEPATOLOGY (2009)
Cancer-associated stroma fibroblasts promote pancreatic tumor progression
Rosa F. Hwang et al.
CANCER RESEARCH (2008)
Blocking transforming growth factor-beta up-regulates E-cadherin and reduces migration and invasion of hepatocellular carcinoma cells
Emilia Fransvea et al.
HEPATOLOGY (2008)
Connective tissue growth factor (CTGF) and cancer progression
Chia-Yu Chu et al.
JOURNAL OF BIOMEDICAL SCIENCE (2008)
LY2109761, a novel transforming growth factor β receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis
Davide Melisi et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Connective tissue growth factor: a fibrogenic master switch in fibrotic liver diseases
Olav A. Gressner et al.
LIVER INTERNATIONAL (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5
Li Liu et al.
CANCER RESEARCH (2006)
All in the CCN family: essential matricellular signaling modulators emerge from the bunker
Andrew Leask et al.
JOURNAL OF CELL SCIENCE (2006)
Matrix metalloproteinases play an active role in Wnt1-induced mammary tumorigenesis
L Blavier et al.
CANCER RESEARCH (2006)
Transforming growth factor-β receptor inhibition enhances adenoviral infectability of carcinoma cells via up-regulation of coxsackie and adenovirus receptor in conjunction with reversal of epithelial-mesenchymal transition
MD Lacher et al.
CANCER RESEARCH (2006)
Updated treatment approach to hepatocellular carcinoma
JM Llovet
JOURNAL OF GASTROENTEROLOGY (2005)
Tumor stroma interactions induce chemoresistance in pancreatic ductal carcinoma cells involving increased secretion and paracrine effects of nitric oxide and in terleukin-1β
S Müerköster et al.
CANCER RESEARCH (2004)
Liver extracellular matrix in health and disease
P Bedossa et al.
JOURNAL OF PATHOLOGY (2003)
Epithelial-mesenchymal transitions in tumour progression
JP Thiery
NATURE REVIEWS CANCER (2002)
Chronic liver injury, TGF-β, and cancer
DM Bissell
EXPERIMENTAL AND MOLECULAR MEDICINE (2001)
Human hepatocellular carcinoma (HCC) cells require both α3β1 integrin and matrix metalloproteinases activity for migration and invasion
G Giannelli et al.
LABORATORY INVESTIGATION (2001)
分享论文
